Kenichi Nomoto

Title: Kenichi Nomoto: Innovator in Cancer Treatment

Introduction

Kenichi Nomoto is a prominent inventor based in Belmont, MA (US). He has made significant contributions to the field of cancer treatment, holding a total of 6 patents. His work focuses on developing therapeutic agents and multikinase inhibitors that target specific types of cancer.

Latest Patents

One of his latest patents is a therapeutic agent for bile duct cancer. This invention provides a compound comprising 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof. Another notable patent involves multikinase inhibitors for use in the treatment of cancer. This invention includes compounds, pharmaceutical compositions, and methods for treating specific cancers, generally comprising a compound of formula (I) and a pharmaceutically acceptable carrier.

Career Highlights

Kenichi Nomoto has worked with notable companies in the pharmaceutical industry, including Eisai R&D Management Co., Ltd. and Eisai Inc. His experience in these organizations has contributed to his expertise in developing innovative cancer treatments.

Collaborations

Throughout his career, Kenichi has collaborated with esteemed colleagues such as Sergei I Agoulnik and Bruce Decosta. These partnerships have further enhanced his research and development efforts in the field of oncology.

Conclusion

Kenichi Nomoto is a dedicated inventor whose work in cancer treatment has the potential to make a significant impact on patient care. His innovative patents and collaborations reflect his commitment to advancing medical science.